SynEVOL R&D advances healthcare through 3D bioprinting, AI-guided nanotechnology, and precision therapeutics. We engineer solutions at the cellular level.
Four pillars of innovation converging at the intersection of biology, technology, and precision medicine.
Custom tissue engineering and personalized regenerative medicine. Building living structures layer by layer for dermatological and reconstructive applications.
AI-guided nanocarrier platforms for targeted drug delivery. 120nm PEGylated liposomal systems with folate receptor precision targeting for cancer therapeutics.
Machine learning models that predict treatment response, optimize drug formulations in real-time, and adapt to individual patient molecular profiles.
Continuous biosignal monitoring devices that feed real-time patient data into our AI systems for adaptive therapeutic response.
Interactive educational resources and published research from the SynEVOL lab.
How plant-based nutrition directly fuels human DNA repair, cellular energy, and biological evolution. Interactive molecular building blocks explorer.
EXPLORE → PublicationsPublished research with Zenodo DOIs, ORCID-linked authorship, SHA-256 verification, and CC BY-NC-ND 4.0 licensing. Real science, real credentials.
VIEW PAPERS → AI ResearchOur AI-powered research partner for generating, reviewing, and publishing scientific papers. Groq-powered with agentic Zenodo publishing pipeline.
LAUNCH AEGIS →Two decades of building at the intersection of technology, biology, and intelligence.
Interdisciplinary researcher bridging AI systems architecture, 3D bioprinting, nanotechnology, wearable health sensors, and cybersecurity applications in healthcare. Leading three organizations since 1994 with certifications from Oxford, UPenn, and IBM.